Tumour dormancy and clinical implications in breast cancer.
about
Tumor dormancy: potential therapeutic target in tumor recurrence and metastasis preventionIL-32 promotes breast cancer cell growth and invasivenessTrefoil Factor-3 (TFF3) Stimulates De Novo Angiogenesis in Mammary Carcinoma both Directly and Indirectly via IL-8/CXCR2.Eukaryotic cell encystation and cancer cell dormancy: is a greater devil veiled in the details of a lesser evil?The influence of vascular endothelial growth factor-A and matrix metalloproteinase-2 and -9 in angiogenesis, metastasis, and prognosis of endometrial cancer.Parallels between hematopoietic stem cell and prostate cancer disseminated tumor cell regulation.
P2860
Tumour dormancy and clinical implications in breast cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Tumour dormancy and clinical implications in breast cancer.
@en
type
label
Tumour dormancy and clinical implications in breast cancer.
@en
prefLabel
Tumour dormancy and clinical implications in breast cancer.
@en
P2093
P2860
P356
P1476
Tumour dormancy and clinical implications in breast cancer
@en
P2093
A Esposito
A Goldhirsch
C Criscitiello
I Minchella
L Fumagalli
M Locatelli
P2860
P356
10.3332/ECANCER.2013.320
P577
2013-05-21T00:00:00Z